feed,title,long_url,short_url
Investing,Sanofi receives FDA complete response letter for MS drug tolebrutinib,https://www.investing.com/news/stock-market-news/sanofi-receives-fda-complete-response-letter-for-ms-drug-tolebrutinib-93CH-4422271,
